This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2rgu
From Proteopedia
(New page: 200px<br /> <applet load="2rgu" size="450" color="white" frame="true" align="right" spinBox="true" caption="2rgu, resolution 2.600Å" /> '''Crystal structure ...) |
|||
| Line 1: | Line 1: | ||
| - | [[Image:2rgu. | + | [[Image:2rgu.jpg|left|200px]]<br /><applet load="2rgu" size="350" color="white" frame="true" align="right" spinBox="true" |
| - | <applet load="2rgu" size=" | + | |
caption="2rgu, resolution 2.600Å" /> | caption="2rgu, resolution 2.600Å" /> | ||
'''Crystal structure of complex of human DPP4 and inhibitor'''<br /> | '''Crystal structure of complex of human DPP4 and inhibitor'''<br /> | ||
| + | |||
| + | ==Overview== | ||
| + | A new chemical class of potent DPP-4 inhibitors structurally derived from, the xanthine scaffold for the treatment of type 2 diabetes has been, discovered and evaluated. Systematic structural variations have led to 1, (BI 1356), a highly potent, selective, long-acting, and orally active, DPP-4 inhibitor that shows considerable blood glucose lowering in, different animal species. 1 is currently undergoing clinical phase IIb, trials and holds the potential for once-daily treatment of type 2, diabetics. | ||
==About this Structure== | ==About this Structure== | ||
| - | 2RGU is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with NAG and 356 as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Dipeptidyl-peptidase_IV Dipeptidyl-peptidase IV], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.14.5 3.4.14.5] Full crystallographic information is available from [http:// | + | 2RGU is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=NAG:'>NAG</scene> and <scene name='pdbligand=356:'>356</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Dipeptidyl-peptidase_IV Dipeptidyl-peptidase IV], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.14.5 3.4.14.5] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2RGU OCA]. |
| + | |||
| + | ==Reference== | ||
| + | 8-(3-(R)-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin -2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a Highly Potent, Selective, Long-Acting, and Orally Bioavailable DPP-4 Inhibitor for the Treatment of Type 2 Diabetes., Eckhardt M, Langkopf E, Mark M, Tadayyon M, Thomas L, Nar H, Pfrengle W, Guth B, Lotz R, Sieger P, Fuchs H, Himmelsbach F, J Med Chem. 2007 Dec 27;50(26):6450-3. Epub 2007 Dec 1. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=18052023 18052023] | ||
[[Category: Dipeptidyl-peptidase IV]] | [[Category: Dipeptidyl-peptidase IV]] | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
| Line 26: | Line 31: | ||
[[Category: transmembrane]] | [[Category: transmembrane]] | ||
| - | ''Page seeded by [http:// | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jan 23 11:13:29 2008'' |
Revision as of 09:13, 23 January 2008
|
Crystal structure of complex of human DPP4 and inhibitor
Overview
A new chemical class of potent DPP-4 inhibitors structurally derived from, the xanthine scaffold for the treatment of type 2 diabetes has been, discovered and evaluated. Systematic structural variations have led to 1, (BI 1356), a highly potent, selective, long-acting, and orally active, DPP-4 inhibitor that shows considerable blood glucose lowering in, different animal species. 1 is currently undergoing clinical phase IIb, trials and holds the potential for once-daily treatment of type 2, diabetics.
About this Structure
2RGU is a Single protein structure of sequence from Homo sapiens with and as ligands. Active as Dipeptidyl-peptidase IV, with EC number 3.4.14.5 Full crystallographic information is available from OCA.
Reference
8-(3-(R)-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin -2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a Highly Potent, Selective, Long-Acting, and Orally Bioavailable DPP-4 Inhibitor for the Treatment of Type 2 Diabetes., Eckhardt M, Langkopf E, Mark M, Tadayyon M, Thomas L, Nar H, Pfrengle W, Guth B, Lotz R, Sieger P, Fuchs H, Himmelsbach F, J Med Chem. 2007 Dec 27;50(26):6450-3. Epub 2007 Dec 1. PMID:18052023
Page seeded by OCA on Wed Jan 23 11:13:29 2008
Categories: Dipeptidyl-peptidase IV | Homo sapiens | Single protein | Eckhardt, M. | Himmelsbach, F. | Nar, H. | 356 | NAG | Aminopeptidase | Glycoprotein | Hydrolase | Inhibitor | Membrane | Peptidase | Protease | Secreted | Serine protease | Signal-anchor | Transmembrane
